📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Accelerating clinical development of a live attenuated vaccine against Salmonella Paratyphi A (VASP): study protocol for an observer-participant-blind randomised control trial of a novel oral vaccine using a human challenge model of Salmonella Paratyphi A infection in healthy adult volunteers (2023)

First Author: McCann N

Attributed to: Development of a Live Attenuated Vaccine Against Salmonella Paratyphi (VASP) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2022-068966

Publication URI: http://dx.doi.org/10.1136/bmjopen-2022-068966

Type: Journal Article/Review

Parent Publication: BMJ Open

Issue: 5